InvestorsHub Logo
Followers 275
Posts 32727
Boards Moderated 0
Alias Born 11/14/2013

Re: foxhound02 post# 6463

Monday, 03/17/2014 2:30:27 PM

Monday, March 17, 2014 2:30:27 PM

Post# of 704246
IMHO, quick does not mean a couple years for each extension trial on Direct (perhaps on L which will become unnecessary IMHO -- and there will be no need for extension trials on Direct -- only post approval trials). The "discussion shifted," because as I have said before, their is an order to things. These 2 treatments are intimately related in NWBO's strategy.

Let me humbly present a homely analogy. Provenge is the blocking fullback. ICT-107 is the tailback.
DCVAX-L is the running back. Percy Harvin is DCVax Direct.

Provenge fakes getting the handoff and makes a critical block, the quarter-back pitches to the tail-back who does a reversal hand-off to the running-back who makes the 20 yard throw down field to Percy Harvin, Percy Harvin outruns everyone on the field. TD.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News